Study of Biodistribution, Metabolism, Excretion and Brain Uptake of 11C-HY-2-15

NCT06032026 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

70

Enrollment

OTHER

Sponsor class

Conditions

Tauopathies

Interventions

DRUG: 11C-HY-2-15 PET
DIAGNOSTIC_TEST: brain MRI
DIAGNOSTIC_TEST: Amyloid PET scan
BEHAVIORAL: Neurological assessments

Sponsor

University of Pennsylvania